Stocktoria
KalVista Pharmaceuticals, Inc. KALV
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2015-04-09
KalVista Pharmaceuticals, Inc. statistics & valuation
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | -280.9% | — | — | — | -319.4% | -184.9% | -222.8% | -1485.3% | -711.7% |
| Net margin | — | -253.3% | — | — | — | -229.4% | -129.1% | -188.3% | -1236.9% | -536.1% |
| FCF margin | — | -178.5% | — | — | — | -354.9% | -232.2% | 108.8% | -1582.2% | -617.3% |
| Return on assets | -73.2% | -53.8% | -50.7% | -40.4% | -17.0% | -31.5% | -17.6% | -25.7% | -54.2% | -46.2% |
| Return on equity | -192.3% | -61.3% | -57.7% | -44.5% | -18.0% | -34.8% | -21.5% | -58.0% | -59.4% | 30.8% |
| Current ratio | 5.35 | 9.90 | 11.46 | 16.73 | 27.04 | 11.49 | 6.40 | 2.56 | 11.33 | 7.59 |
Source: SEC EDGAR filings · CIK 0001348911 · US · as of 2025-04-30. facts plus Stocktoria's own computed scores — not investment advice.